Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (9) clinical trials

This is a Phase II, Randomized, Double-Blind, And Placebo-Controlled. To investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough,aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.


A single ascending dose study of the safety and immunogenicity of NasoVAX. An intranasal flu vaccine


Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

This is a multi-center, randomized, double blind active-controlled Phase 2b study. 222 subjects will be randomized 1:1:1 into three groups to receive two sequential non-adjuvanted 0.5 mg or 1.0mg intramuscular injection of M-001 (treatment), or two placebo (saline) injection, before receiving the Alum adjuvanted H5N1 vaccine at a sub optimal ...


Safety and Immunogenicity of IVACFLU-A/H5N1 in Vietnamese Adult

In the Phase 2 study, 300 healthy adult subjects will be randomised to 3 groups (100 subjects/group), receiving 2 doses of vaccine (either 15ug/dose or 30ug/dose) or 2 doses of saline placebo. Safety and immunogenicity after each dose of vaccine will be assessed in all 300 subjects. Although full evaluation ...


A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

This is a Phase 2 randomized, placebo- and active-controlled, two-part study in which healthy adult volunteers with low or undetectable pre-existing antibodies against A/California/7/2009(H1N1) pdm09-like virus will be challenged with an influenza A/H1N1 human challenge strain approximately 90 days after vaccination with a single dose of H1N1 HA Adenoviral-vector based ...


Study of VIS410 in Subjects With Uncomplicated Influenza A

Subjects will be admitted to an infusion unit for drug administration and observation following infusion. The study is designed to compare an infusion of a single high or low IV dose of VIS410 against placebo. Subjects will be followed for 100 (±7 days).


Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX

This is a Phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of NasoVAX in healthy adults 18 to 49 years of age. Subjects will be screened within 28 days of randomization (Day 1). Approximately 60 subjects who meet all inclusion and no exclusion criteria and provide ...